BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Zhong D. [Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi 2018;21:686-91. [PMID: 30201068 DOI: 10.3779/j.issn.1009-3419.2018.09.07] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Zhong WX, Wei XF. Coexistence of anaplastic lymphoma kinase rearrangement in lung adenocarcinoma harbouring epidermal growth factor receptor mutation: A single-center study. World J Clin Cases 2022; 10(33): 12164-12174 [DOI: 10.12998/wjcc.v10.i33.12164] [Reference Citation Analysis]
2 Lu Z, Wang X, Luo Y, Wei J, Zeng Z, Xiong Q, Cai J, Liu A. EGFR (p. G719A+L747V)/EML4-ALK Co-alterations in Lung Adenocarcinoma with Leptomeningeal Metastasis Responding to Afatinib Treatment: A Case Report. Onco Targets Ther 2021;14:2823-8. [PMID: 33935502 DOI: 10.2147/OTT.S294635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Shao Y, Zhong D. [Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI]. Zhongguo Fei Ai Za Zhi 2020;23:381-7. [PMID: 32429639 DOI: 10.3779/j.issn.1009-3419.2020.101.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]